APIM
ABBV icon

Agate Pass Investment Management’s AbbVie ABBV Stock Holding History

Agate Pass Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
54,306
-12,745
-19% -$2.74M 5.04% 3
2026
Q1 		$14.6M Sell
67,051
-172
-0.3% -$38.2K 5.71% 1
2025
Q4 		$15.4M Sell
67,223
-152
-0.2% -$34.6K 5.71% 2
2025
Q3 		$15.6M Sell
67,375
-711
-1% -$145K 5.94% 1
2025
Q2 		$12.6M Hold
68,086
– – 5.19% 1
2025
Q1 		$14.3M Buy
68,086
+3,130
+5% +$608K 6.1% 1
2024
Q4 		$11.5M Buy
64,956
+5,314
+9% +$977K 5.22% 3
2024
Q3 		$11.8M Sell
59,642
-390
-0.6% -$72.8K 5.88% 1
2024
Q2 		$10.3M Buy
60,032
+60
+0.1% +$9.94K 5.48% 1
2024
Q1 		$10.9M Buy
59,972
+3,401
+6% +$586K 5.86% 1
2023
Q4 		$8.77M Sell
56,571
-109
-0.2% -$15.9K 5.08% 2
2023
Q3 		$8.45M Hold
56,680
– – 5.73% 1
2023
Q2 		$7.64M Hold
56,680
– – 4.63% 5
2023
Q1 		$9.03M Buy
56,680
+2,810
+5% +$430K 5.91% 1
2022
Q4 		$8.71M Buy
53,870
+1,543
+3% +$237K 6.16% 1
2022
Q3 		$7.02M Hold
52,327
– – 5.36% 1
2022
Q2 		$8.01M Buy
52,327
+8
+0% +$1.22K 5.64% 1
2022
Q1 		$8.48M Hold
52,319
– – 5.29% 1
2021
Q4 		$7.08M Buy
+52,319
New +$6.18M 4.41% 5

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Agate Pass Investment Management's ABBV Position: Q2 2026 in Review

Agate Pass Investment Management reduced its AbbVie (ABBV) stake by 19% in Q2 2026, selling an estimated $2.74M and leaving 54,306 shares worth $13.7M. The position accounts for 5.04% of the portfolio, ranked #3.

Agate Pass Investment Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $15.6M in Q3 2025. 1,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Agate Pass Investment Management held 54,306 shares of AbbVie worth $13.7M as of Q2 2026.
  • Agate Pass Investment Management sold 12,745 AbbVie shares in Q2 2026, an estimated $2.74M.
  • AbbVie made up 5.04% of Agate Pass Investment Management's portfolio in Q2 2026, its #3 holding.
  • Agate Pass Investment Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Agate Pass Investment Management's AbbVie position peaked at $15.6M in Q3 2025.
  • 1,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Agate Pass Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.